CAS 1196835-68-3

(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propa n-2-yl)nonanamide, but-2-enedioic acid

CAS : 1196835-68-3

(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-[(4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-- 8-methylnonanamide butanedioic acid is a degradable drug that has vasodilatory effects on the circulatory system. It is used in clinical studies for the treatment of cardiovascular disorders such as cardiac hypertrophy and hypertension. This drug is also used to diagnose diseases such as aortic aneurysms and myocardial infarctions. The drug can be taken orally or intravenously via a solid oral formulation. (2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2,2-dimethylethyl)-4hydroxy

Formule : C₃₄H₅₇N₃O₁₀

Degré de pureté : Min. 95%

Masse moléculaire : 667.8 g/mol

Ref: 3D-WXB83568

Aliskiren fumarate

CAS : 1196835-68-3

Oral renin inhibitor Aliskiren fumarate treats hypertension; IC50: 1.5 nM. Useful for cardiovascular and cancer cachexia research.

Formule : C₃₄H₅₇N₃O₁₀

Couleur et forme : Solid

Masse moléculaire : 667.83

Ref: TM-T72526